Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.01−0.08 (-2.59%)
Close on Nov 12, 2026Market cap $121.53MP/E –Yield –
Molecular Partners total assets
Total assets on the balance sheet at the end of each period.
Molecular Partners's total assets was CHF 75.70M at Jun 30, 2026. For fiscal 2025 it was CHF 102.11M, down 35.6% from the year before. The highest annual figure on record is CHF 262.26M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 102.11M | -35.6% |
| FY2024 | Dec 31, 2024 | CHF 158.53M | -20.1% |
| FY2023 | Dec 31, 2023 | CHF 198.35M | -24.4% |
| FY2022 | Dec 31, 2022 | CHF 262.26M | +51.9% |
| FY2021 | Dec 31, 2021 | CHF 172.67M | -7.9% |
| FY2020 | Dec 31, 2020 | CHF 187.55M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 75.70M | -55.6% |
| Q4 FY2025 | Dec 31, 2025 | CHF 102.11M | -48.5% |
| Q2 FY2025 | Jun 30, 2025 | CHF 124.25M | -46.1% |
| Q4 FY2024 | Dec 31, 2024 | CHF 158.53M | -39.6% |
| Q2 FY2024 | Jun 30, 2024 | CHF 170.62M | -43.0% |
| Q4 FY2023 | Dec 31, 2023 | CHF 198.35M | +14.9% |
| Q2 FY2023 | Jun 30, 2023 | CHF 230.49M | +22.9% |
| Q4 FY2022 | Dec 31, 2022 | CHF 262.26M | – |
| Q2 FY2022 | Jun 30, 2022 | CHF 299.29M | – |
| Q4 FY2021 | Dec 31, 2021 | CHF 172.67M | – |
| Q4 FY2020 | Dec 31, 2020 | CHF 187.55M | – |
See a number that looks wrong?